Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Launched by POWER LIFE SCIENCES INC. · Sep 16, 2022
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the experiences of people with leiomyosarcoma, a type of cancer, when they participate in medical research. The goal is to gather information about the challenges that patients face when joining clinical trials and to understand why some people may choose to drop out or not participate at all. By collecting this data, researchers hope to improve the way clinical trials are conducted in the future and make them more accessible to everyone.
To be eligible for this study, you need to be at least 18 years old and have been diagnosed with leiomyosarcoma. You should also be planning to take part in an interventional clinical trial, which means you would be receiving a new treatment as part of the study. If you join, you will share your experiences, which will help researchers analyze the data and potentially improve the trial process for others. It's important to know that the study is not yet recruiting participants, but it aims to include people of all genders and a wide range of backgrounds.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient has self-identified as planning to enroll in an interventional clinical trial
- • Patient has been diagnosed with leiomyosarcoma
- • Patient is a minimum of 18 years or older
- Exclusion Criteria:
- • Patient does not understand, sign, and return consent form
- • Inability to perform regular electronic reporting
- • Patient is pregnant
- • ECOG score of 4
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials